Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are by far the most maturely made TPD approaches. On this evaluation, we focus on both preclinical experiments and scientific trials to supply a comprehensive summary of the protection and scientific efficiency of PROTACs and MGDs in hematologic malignancies over the https://md-22444210.newsbloger.com/32593806/lomitapide-options